EG19368A - Method for preparing of salt of ranitidine and a complex of bismuth in the treatment of gastrointe-stinal disorders. - Google Patents

Method for preparing of salt of ranitidine and a complex of bismuth in the treatment of gastrointe-stinal disorders.

Info

Publication number
EG19368A
EG19368A EG34289A EG34289A EG19368A EG 19368 A EG19368 A EG 19368A EG 34289 A EG34289 A EG 34289A EG 34289 A EG34289 A EG 34289A EG 19368 A EG19368 A EG 19368A
Authority
EG
Egypt
Prior art keywords
gastrointe
stinal
ranitidine
bismuth
disorders
Prior art date
Application number
EG34289A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888817098A external-priority patent/GB8817098D0/en
Priority claimed from GB898904686A external-priority patent/GB8904686D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of EG19368A publication Critical patent/EG19368A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
EG34289A 1988-07-18 1989-07-17 Method for preparing of salt of ranitidine and a complex of bismuth in the treatment of gastrointe-stinal disorders. EG19368A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888817098A GB8817098D0 (en) 1988-07-18 1988-07-18 Chemical compounds
GB898904686A GB8904686D0 (en) 1989-03-01 1989-03-01 Chemical compounds

Publications (1)

Publication Number Publication Date
EG19368A true EG19368A (en) 1995-02-28

Family

ID=26294175

Family Applications (1)

Application Number Title Priority Date Filing Date
EG34289A EG19368A (en) 1988-07-18 1989-07-17 Method for preparing of salt of ranitidine and a complex of bismuth in the treatment of gastrointe-stinal disorders.

Country Status (35)

Country Link
US (1) US5008256A (zh)
JP (1) JP2523185B2 (zh)
KR (1) KR0122598B1 (zh)
CN (1) CN1022626C (zh)
AT (1) AT398200B (zh)
AU (1) AU632052B2 (zh)
BE (1) BE1003254A5 (zh)
CA (1) CA1332610C (zh)
CH (1) CH679582A5 (zh)
CY (1) CY1650A (zh)
DE (1) DE3923638C2 (zh)
DK (1) DK168381B1 (zh)
EG (1) EG19368A (zh)
ES (1) ES2014175A6 (zh)
FI (1) FI90538C (zh)
FR (1) FR2634122B1 (zh)
GB (1) GB2220937B (zh)
GR (1) GR1000431B (zh)
HK (1) HK61392A (zh)
HU (2) HU206104B (zh)
IE (1) IE61076B1 (zh)
IL (1) IL91005A (zh)
IT (1) IT1231481B (zh)
LU (2) LU87557A1 (zh)
MX (1) MX174145B (zh)
MY (1) MY104055A (zh)
NL (2) NL192604C (zh)
NO (2) NO176319C (zh)
NZ (1) NZ229958A (zh)
PL (1) PL162391B1 (zh)
PT (1) PT91188B (zh)
SE (1) SE468715B (zh)
SG (1) SG51992G (zh)
YU (1) YU47021B (zh)
ZW (1) ZW8689A1 (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009240D0 (en) * 1990-04-25 1990-06-20 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
AU648574B2 (en) * 1990-07-20 1994-04-28 Tillotts Pharma Ag Products and processes for the treatment of the alimentary canal
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
WO1996019232A1 (en) * 1994-12-19 1996-06-27 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
US6117412A (en) * 1995-01-26 2000-09-12 Nycomed Imaging As Non-cluster type bismuth compounds
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
EP1035192A1 (de) * 1999-01-26 2000-09-13 Stefan Graichen Additiv für einen Kühlschmierstoff
CN1102585C (zh) * 1999-04-28 2003-03-05 常州兰陵制药有限公司 雷尼替丁枸橼酸铋盐的制备方法
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
CN100402514C (zh) * 2006-08-01 2008-07-16 丽珠医药集团股份有限公司 一种制备枸橼酸铋雷尼替丁的方法
CN101484132A (zh) * 2007-07-09 2009-07-15 柏树制药公司 具有合意口味的雷尼替丁制剂
CN102408398B (zh) * 2011-09-20 2012-12-05 江苏汉斯通药业有限公司 枸橼酸铋雷尼替丁的制备方法
US9731999B2 (en) 2011-09-23 2017-08-15 Iqbal Gill Chemical admixtures for hydraulic cements
ES2426539B1 (es) * 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN103896888B (zh) * 2014-03-28 2015-11-18 常州兰陵制药有限公司 枸橼酸铋雷尼替丁的制备方法
WO2015155297A1 (en) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
WO2015169957A1 (en) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists
CN107382921A (zh) * 2017-07-28 2017-11-24 常州兰陵制药有限公司 制备枸橼酸铋雷尼替丁的方法
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FR2531706A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
BE905235A (fr) * 1986-08-05 1986-12-01 Hasunor Ag Ascorbates antagonistes des recepteurs h2 et leur procede de preparation.
IT1215325B (it) * 1987-01-07 1990-02-08 Barisintex Sa Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
NO176319C (no) 1995-03-15
DK168381B1 (da) 1994-03-21
NL970046I1 (nl) 1998-03-02
CA1332610C (en) 1994-10-18
NZ229958A (en) 1991-09-25
AU632052B2 (en) 1992-12-17
IE892309L (en) 1990-01-18
IT1231481B (it) 1991-12-07
FR2634122B1 (fr) 1993-11-19
NO892936L (no) 1990-01-19
YU142789A (en) 1991-04-30
DE3923638C2 (de) 1995-11-23
NL8901840A (nl) 1990-02-16
FI90538B (fi) 1993-11-15
IE61076B1 (en) 1994-09-21
NL970046I2 (nl) 1998-04-01
MY104055A (en) 1993-10-30
GR890100454A (en) 1990-06-27
ES2014175A6 (es) 1990-06-16
GB2220937B (en) 1991-11-27
MX174145B (es) 1994-04-25
KR0122598B1 (ko) 1997-11-13
CN1039419A (zh) 1990-02-07
GB2220937A (en) 1990-01-24
CN1022626C (zh) 1993-11-03
NO1998007I1 (no) 1998-02-05
US5008256A (en) 1991-04-16
DK351789D0 (da) 1989-07-17
GB8916288D0 (en) 1989-08-31
CY1650A (en) 1992-12-11
SE8902550L (sv) 1990-01-19
SE8902550D0 (sv) 1989-07-17
FI90538C (fi) 1994-02-25
FI893448A0 (fi) 1989-07-17
JPH02117684A (ja) 1990-05-02
IT8948196A0 (it) 1989-07-17
NO176319B (no) 1994-12-05
DK351789A (da) 1990-01-19
PT91188A (pt) 1990-02-08
NL192604B (nl) 1997-07-01
LU87557A1 (fr) 1990-07-24
ZW8689A1 (en) 1990-02-21
SE468715B (sv) 1993-03-08
NO892936D0 (no) 1989-07-17
GR1000431B (el) 1992-07-30
PL162391B1 (pl) 1993-10-30
SG51992G (en) 1992-07-24
AT398200B (de) 1994-10-25
CH679582A5 (zh) 1992-03-13
AU3817889A (en) 1990-01-18
PT91188B (pt) 1995-03-01
HU206104B (en) 1992-08-28
IL91005A (en) 1994-10-07
IL91005A0 (en) 1990-02-09
FR2634122A1 (fr) 1990-01-19
HU211173A9 (en) 1995-11-28
ATA172889A (de) 1994-02-15
DE3923638A1 (de) 1990-03-01
MX16829A (es) 1993-10-01
YU47021B (sh) 1994-11-15
BE1003254A5 (fr) 1992-02-11
JP2523185B2 (ja) 1996-08-07
HK61392A (en) 1992-08-21
HUT52082A (en) 1990-06-28
NL192604C (nl) 1997-11-04
FI893448A (fi) 1990-01-19
LU88722I2 (fr) 1996-08-23
KR910002826A (ko) 1991-02-26

Similar Documents

Publication Publication Date Title
EG19368A (en) Method for preparing of salt of ranitidine and a complex of bismuth in the treatment of gastrointe-stinal disorders.
NZ227332A (en) Ribozymes, production and use
DE3760201D1 (en) (-)-benzhydrylsulfinylacetamide, process for its preparation and its use in therapy
GB2187536B (en) Bioprosthetic heart valve, methods and device for preparation thereof
DE3480209D1 (en) Polyimide, process for its preparation and its use
HUT45523A (en) Herbicides comprising pyridine-sulfonamide derivatives and process for producing the active ingredients
IL73159A (en) Carboxyalkenamido-cephalosporins,processes for the preparation thereof and methods for the use thereof
DE3461466D1 (en) 3',4',5,7-tetrahydroxyflavone derivatives, process for their preparation and their therapeutical use
IL83338A0 (en) 3-aryluracils,their manufacture and their use for controlling weeds
GR3018009T3 (en) Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained.
ZA881710B (en) Oil-in-water emulsions,a process for their preparation and their use
IL87089A0 (en) N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy
DE3466539D1 (en) 4'-flavonecarboxylic acids, process for their preparation and their therapeutical use
AR242431A1 (es) Limpiador abrasivo espesado vertible y metodo para prepararlo.
GR871880B (en) Arrangement and method for producing cheese using the filteration method
ZA844539B (en) 3-phenyl-4-cyanopyrrole derivatives,the preparation thereof,and method of use thereof as microbicides
ZA842223B (en) Method for the preparation of 1,8-dihydroxy-10-acyl-9-anthrones,especially for use in the treatment of psoriasis
EP0121081A3 (en) Azolylmethylcycloalkanes, process for their preparation and their therapeutical use
GB2207849B (en) A fresh and creamy spread and process for preparing the spread.
HUT44906A (en) Herbicides comprising imino-oxazolidine derivatives and process for producing the active ingredients
IL92033A0 (en) Catalyst and method for the preparation thereof
EG18799A (en) Phenylthioureas, phenylisothioureas and phenylcarbodumides their preparation and use in the control of pests
HUT48868A (en) Fungicides comprising n,n'-diacylaminals and process for producing the active ingredients
ZA875993B (en) Heteroarylethylamines,processes for the preparation thereof,and the use thereof as production promotors in livestock
DE3760507D1 (en) 1,2-dichloro-1,2,2-trimethyl-1-phenyldisilane and method for producing the same